SEC Comment Letter for PLUS THERAPEUTICS, INC. (CNSY) (CIK 0001095981) (CNSY) — May 19, 2017
PLUS THERAPEUTICS, INC. (CNSY) (CIK 0001095981)
Date: May 19, 2017 · CIK: 0001095981 · Accession: 0000000000-17-017699
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-217988
Letter
Mail Stop 3030 May 19 , 2017 Marc H. Hedrick, M.D. President and Chief Executive Officer Cytori Therapeutics , Inc. 3020 Callan Road San Diego, California 92121
Re: Cytori Therapeutics , Inc. Registration Statement on Form S-3 Filed May 12, 2017 File No. 333-217988
Dear Dr. Hedrick :
This is to advise you that we have not reviewed and will not review your registration statement .
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Tim Buchmiller at (202) 551 -3635 with any questions.
Sincerely,
/s/ Tim Buchmiller for
Show Raw Text
Mail Stop 3030 May 19 , 2017 Marc H. Hedrick, M.D. President and Chief Executive Officer Cytori Therapeutics , Inc. 3020 Callan Road San Diego, California 92121 Re: Cytori Therapeutics , Inc. Registration Statement on Form S-3 Filed May 12, 2017 File No. 333-217988 Dear Dr. Hedrick : This is to advise you that we have not reviewed and will not review your registration statement . Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Tim Buchmiller at (202) 551 -3635 with any questions. Sincerely, /s/ Tim Buchmiller for Amanda Ravitz Assistant Director Office of Electronics and Machinery cc: Cheston J. Larson , Esq. Latham & Watkins LLP